{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:49:50Z","timestamp":1777416590696,"version":"3.51.4"},"reference-count":20,"publisher":"SAGE Publications","issue":"7-8","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[1999,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To report toxicity resulting from donepezil administration following a tenfold dosing error.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CASE SUMMARY:<\/jats:title>\n                    <jats:p>A 79-year-old white nursing home patient with a history of Alzheimer disease and hypertension was inadvertently given 50 mg of donepezil instead of her usual 5-mg dose. She presented to the emergency department with nausea, vomiting, and persistent bradycardia (HR in the 40s). Routine laboratory studies were all within normal limits. Basilar rales were noted five hours after arrival. She was treated with atropine 0.2 mg as needed for bradycardia (HR &lt;50 beats\/min); a total of 3.0 mg was administered over 18 hours. Each bolus kept her HR &gt;60 beats\/min for one-half to two hours. No further vomiting or evidence of pulmonary edema occurred after her initial episodes. She returned to baseline by day 2 (HR in the 70s) and was returned to the nursing home.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>Donepezil is a centrally acting, reversible cholinesterase inhibitor that is used in the treatment of Alzheimer disease. Donepezil is highly specific for neural acetylcholinesterases, preferentially binding acetylcholinesterase by greater than three orders of magnitude over butyrylcholinesterases. This specificity minimizes peripheral adverse effects at therapeutic doses. Our patient mainly experienced bradycardia and had minimal secretory effects compared with what is usually seen with nonspecific cholinesterase inhibition. Medication errors like the one that produced this overdose are a common but preventable cause of morbidity in healthcare facilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>A tenfold dosing error caused donepezil toxicity. The main effect of this overdose was bradycardia, which responded to atropine therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.18273","type":"journal-article","created":{"date-parts":[[2004,3,11]],"date-time":"2004-03-11T17:08:19Z","timestamp":1079024899000},"page":"812-815","source":"Crossref","is-referenced-by-count":47,"title":["Donepezil Overdose: A Tenfold Dosing Error"],"prefix":"10.1177","volume":"33","author":[{"given":"Greene","family":"Shepherd","sequence":"first","affiliation":[{"name":"Greene Shepherd PharmD, at time of writing, Clinical Toxicology Fellow, Maryland Poison Center, School of Pharmacy, University of Maryland, Baltimore, MD; now, Clinical Toxicologist, North Texas Poison Center, Parkland Memorial Hospital, Dallas, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Klein-Schwartz","sequence":"additional","affiliation":[{"name":"Wendy Klein-Schwartz PharmD MPH, Coordinator of Research and Education, Maryland Poison Center, School of Pharmacy, University of Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Edwards","sequence":"additional","affiliation":[{"name":"Robin Edwards MD, Attending Physician, Department of Emergency Medicine, Union Memorial Hospital, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1999,7,1]]},"reference":[{"key":"bibr1-aph.18273","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(97)00079-5"},{"key":"bibr2-aph.18273","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0896(96)00137-X"},{"key":"bibr3-aph.18273","volume-title":"Package insert. Aricept (donepezil)","year":"1996"},{"key":"bibr4-aph.18273","first-page":"2348","volume-title":"Harrison's principles of internal medicine","author":"Bird TD","year":"1998","edition":"14"},{"key":"bibr5-aph.18273","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/54.24.2805"},{"key":"bibr6-aph.18273","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb01945.x"},{"key":"bibr7-aph.18273","first-page":"1429","volume-title":"Goldfrank's toxicologic emergencies","author":"Aaron CK","year":"1998","edition":"6"},{"key":"bibr8-aph.18273","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04134.x"},{"key":"bibr9-aph.18273","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0112e"},{"key":"bibr10-aph.18273","first-page":"161","volume-title":"Goodman and Gilman's the pharmacologic basis of therapeutics","author":"Taylor P","year":"1996","edition":"9"},{"key":"bibr11-aph.18273","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(80)80232-0"},{"key":"bibr12-aph.18273","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-1124(76)80253-5"},{"key":"bibr13-aph.18273","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(68)90425-X"},{"key":"bibr14-aph.18273","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1983.tb05093.x"},{"key":"bibr15-aph.18273","volume-title":"Issues excerpted from medication error analysis \u2014 June 30, 1993 through June 1, 1994","author":"Gish FL","year":"1994"},{"key":"bibr16-aph.18273","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"bibr17-aph.18273","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1996.tb02439.x"},{"key":"bibr18-aph.18273","first-page":"173","volume":"89","author":"McGoodwin L","year":"1996","journal-title":"J Okla State Med Assoc"},{"key":"bibr19-aph.18273","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/52.4.390"},{"key":"bibr20-aph.18273","first-page":"305","volume":"50","year":"1993","journal-title":"Am J Hosp Pharm"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.18273","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.18273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:02:24Z","timestamp":1777374144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.18273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":20,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["10.1345\/aph.18273"],"URL":"https:\/\/doi.org\/10.1345\/aph.18273","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}